Pediatrix Medical Group, Inc. (NYSE:MD) Shares Purchased by SG Americas Securities LLC

SG Americas Securities LLC boosted its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 194.0% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 38,405 shares of the company's stock after purchasing an additional 25,343 shares during the quarter. SG Americas Securities LLC's holdings in Pediatrix Medical Group were worth $556,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also added to or reduced their stakes in the business. California State Teachers Retirement System boosted its holdings in Pediatrix Medical Group by 0.9% in the fourth quarter. California State Teachers Retirement System now owns 80,327 shares of the company's stock worth $1,054,000 after acquiring an additional 752 shares in the last quarter. Parkside Financial Bank & Trust raised its stake in shares of Pediatrix Medical Group by 36.1% in the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company's stock worth $51,000 after purchasing an additional 1,040 shares during the last quarter. Nomura Asset Management Co. Ltd. raised its stake in shares of Pediatrix Medical Group by 95.3% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock worth $33,000 after purchasing an additional 1,220 shares during the last quarter. GAMMA Investing LLC raised its stake in shares of Pediatrix Medical Group by 219.5% in the first quarter. GAMMA Investing LLC now owns 2,569 shares of the company's stock worth $37,000 after purchasing an additional 1,765 shares during the last quarter. Finally, AlphaQuest LLC raised its stake in shares of Pediatrix Medical Group by 65.9% in the fourth quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock worth $66,000 after purchasing an additional 2,012 shares during the last quarter. Institutional investors and hedge funds own 97.71% of the company's stock.

Pediatrix Medical Group Stock Performance

MD stock traded up $0.10 during trading on Tuesday, hitting $13.47. 549,820 shares of the company traded hands, compared to its average volume of 739,194. The company has a market cap of $1.16 billion, a PE ratio of -13.33, a P/E/G ratio of 0.90 and a beta of 1.27. Pediatrix Medical Group, Inc. has a 1 year low of $6.62 and a 1 year high of $17.67. The stock's 50-day simple moving average is $13.66 and its 200 day simple moving average is $13.92. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.81 and a quick ratio of 1.81.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its quarterly earnings data on Tuesday, May 6th. The company reported $0.33 EPS for the quarter, beating analysts' consensus estimates of $0.25 by $0.08. The business had revenue of $458.36 million during the quarter, compared to analysts' expectations of $451.44 million. Pediatrix Medical Group had a positive return on equity of 17.43% and a negative net margin of 4.17%. The business's revenue was down 7.4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.20 earnings per share. On average, equities analysts expect that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.

Analyst Ratings Changes

MD has been the subject of several research analyst reports. UBS Group reduced their price objective on Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating for the company in a research note on Monday, May 12th. Macquarie raised their price objective on Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an "outperform" rating in a research note on Thursday, May 8th. Finally, Truist Financial reduced their price objective on Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating for the company in a research note on Friday, April 11th. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat, Pediatrix Medical Group has a consensus rating of "Hold" and a consensus price target of $16.67.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.